1
|
Ando Y, Tahara H, Narimatsu K, Hokari R. Gastrointestinal: Impending rupture of a descending aortic aneurysm presenting as an esophageal submucosal tumor-like elevation. J Gastroenterol Hepatol 2024. [PMID: 38738837 DOI: 10.1111/jgh.16607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2024] [Accepted: 04/29/2024] [Indexed: 05/14/2024]
Affiliation(s)
- Y Ando
- Department of Gastroenterology, National Defense Medical College, Tokorozawa City, Saitama, Japan
| | - H Tahara
- Department of Gastroenterology, National Defense Medical College, Tokorozawa City, Saitama, Japan
| | - K Narimatsu
- Department of Gastroenterology, National Defense Medical College, Tokorozawa City, Saitama, Japan
| | - R Hokari
- Department of Gastroenterology, National Defense Medical College, Tokorozawa City, Saitama, Japan
| |
Collapse
|
2
|
Ando Y, Ono Y, Sano A, Fujita N, Ono S, Tanaka Y. Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases. J Endocrinol Invest 2022; 45:2313-2328. [PMID: 35857218 DOI: 10.1007/s40618-022-01868-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Accepted: 07/08/2022] [Indexed: 10/17/2022]
Abstract
PURPOSE Pheochromocytoma crisis is a life-threatening endocrine emergency that requires prompt diagnosis and treatment. Because of its rarity, sudden onset, and lack of internationally uniform and validated diagnostic criteria, pheochromocytoma crisis remains to be fully clarified. Therefore, we aimed to describe the clinical characteristics and outcomes of pheochromocytoma crisis through a literature review. METHODS We performed a systematic literature search of PubMed/MEDLINE database, Igaku-Chuo-Zasshi (Japanese database), and Google Scholar to identify case reports of pheochromocytoma crisis published until February 5, 2021. Information was extracted and analyzed from the literature that reported adequate individual patient data of pheochromocytoma crisis in English or Japanese. Cases were also termed as pheochromocytoma multisystem crisis (PMC) if patients had signs of hyperthermia, multiple organ failure, encephalopathy, and labile blood pressure. RESULTS In the 200 cases of pheochromocytoma crisis identified from 187 articles, the mean patient age was 43.8 ± 15.5 years. The most common symptom was headache (39.5%). The heart was the most commonly damaged organ resulting from a complication of a pheochromocytoma crisis (99.0%), followed by the lungs (44.0%) and the kidney (21.5%). PMC accounted for 19.0% of all pheochromocytoma crisis cases. After excluding 12 cases with unknown survival statuses, the mortality rate was 13.8% (26/188 cases). Multivariable logistic regression analysis revealed that nausea and vomiting were significantly associated with a higher mortality rate. CONCLUSION Pheochromocytoma can present with different symptomatology, affecting different organ systems. Clinicians should be aware that patients with nausea or vomiting are at a higher risk of death because of pheochromocytoma crisis.
Collapse
Affiliation(s)
- Y Ando
- Department of General Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan
- Department of Family Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
| | - Y Ono
- Department of General Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
| | - A Sano
- Department of General Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan
| | - N Fujita
- Department of General Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan
| | - S Ono
- Department of Eat-Loss Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
| | - Y Tanaka
- Department of General Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan
| |
Collapse
|
3
|
Puviani M, Baum A, Ono S, Ando Y, Hackl R, Manske D. Puviani et al. Reply. Phys Rev Lett 2022; 129:199702. [PMID: 36399762 DOI: 10.1103/physrevlett.129.199702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Accepted: 10/05/2022] [Indexed: 06/16/2023]
Affiliation(s)
- M Puviani
- Max Planck Institute for Solid State Research, 70569 Stuttgart, Germany
| | - A Baum
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - S Ono
- Central Research Institute of Electric Power Industry, Yokosuka, 240-0196 Kanagawa, Japan
| | - Y Ando
- Institute of Physics II, University of Cologne, 50937 Köln, Germany
| | - R Hackl
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - D Manske
- Max Planck Institute for Solid State Research, 70569 Stuttgart, Germany
| |
Collapse
|
4
|
Yokoyama S, Kikuchi R, Matsuyama H, Ohashi K, Watarai R, Hayashi G, Numata Y, Hagiwara T, Kobayashi T, Ando Y, Matsushita T. M022 Performance evaluation of microslide and open channel on VITROS XT 7600 – Establish a clinical testing system for clinical chemistry in the event of a disaster-. Clin Chim Acta 2022. [DOI: 10.1016/j.cca.2022.04.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Puviani M, Baum A, Ono S, Ando Y, Hackl R, Manske D. Calculation of an Enhanced A_{1g} Symmetry Mode Induced by Higgs Oscillations in the Raman Spectrum of High-Temperature Cuprate Superconductors. Phys Rev Lett 2021; 127:197001. [PMID: 34797154 DOI: 10.1103/physrevlett.127.197001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 05/20/2021] [Accepted: 09/30/2021] [Indexed: 06/13/2023]
Abstract
In superconductors the Anderson-Higgs mechanism allows for the existence of a collective amplitude (Higgs) mode which can couple to eV light mainly in a nonlinear Raman-like process. The experimental nonequilibrium results on isotropic superconductors have been explained going beyond the BCS theory including the Higgs mode. Furthermore, in anisotropic d-wave superconductors strong interaction effects with other modes are expected. Here we calculate the Raman contribution of the Higgs mode from a new perspective, including many-body Higgs oscillations effects and their consequences in conventional, spontaneous Raman spectroscopy. Our results suggest a significant contribution to the intensity of the A_{1g} symmetry Raman spectrum in d-wave superconductors. In order to test our theory, we predict the presence of measurable characteristic oscillations in THz quench-optical probe time-dependent reflectivity experiments.
Collapse
Affiliation(s)
- M Puviani
- Max Planck Institute for Solid State Research, 70569 Stuttgart, Germany
| | - A Baum
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - S Ono
- Central Research Institute of Electric Power Industry, Yokosuka, 240-0196 Kanagawa, Japan
| | - Y Ando
- Institute of Physics II, University of Cologne, 50937 Köln, Germany
| | - R Hackl
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - D Manske
- Max Planck Institute for Solid State Research, 70569 Stuttgart, Germany
| |
Collapse
|
6
|
Imataka G, Ishii J, Ando Y, Yoshihara S, Takagi Y, Nitta A, Arisaka O, Yoshihara S. Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency. Eur Rev Med Pharmacol Sci 2020; 24:10051-10053. [PMID: 33090410 DOI: 10.26355/eurrev_202010_23220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
OBJECTIVE Long-term survival of patients with neonatal-onset carbamoyl-phosphate synthetase 1 deficiency (CPS1D), an autosomal recessive disorder characterized by repeated, life-threatening hyperammonemia, is rare. We describe the diagnosis and clinical management of a teenager with neonatal-onset CPS1D who did not undergo therapeutic liver transplantation. CASE REPORT Following emergent neonatal therapy, the patient was diagnosed with CPS1D based on clinical, radiological, biochemical and genetic analyses. Her clinical course, neurobehavioral development and therapeutic interventions are presented and discussed. RESULTS Born from nonconsanguineous parents, the proband underwent phototherapy for neonatal jaundice, associated with acute encephalopathy, apnea and cerebral edema. Based on blood and urinary biochemical abnormalities, neonatal-onset CPS1D was diagnosed. Her hyperammonemia was corrected by hemodialysis, followed by sodium benzoate, L-arginine, levocarnitine and protein-free diet therapy. Because of a relapse and persistent neurobehavioral regression by age 1, a planned liver transplantation was cancelled. At age 10, sodium phenylbutyrate was substituted as ammonia scavenger. Genetic testing revealed compound heterozygote c.2359C>T (R787X) and c.236+6T>C variants of CPS1, confirming her diagnosis. Despite severe neurological sequelae, the patient is 16 and in stable condition. CONCLUSIONS Our case suggests that early hemodialysis and pharmacologic interventions for acute neonatal hyperammonemia can improve the prognosis of patients with neonatal-onset CPS1D.
Collapse
Affiliation(s)
- G Imataka
- Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Roslan AS, Ismail A, Ando Y, Azlan A. Effect of drying methods and parameters on the antioxidant properties of tea (Camellia sinensis) leaves. Food Prod Process and Nutr 2020. [DOI: 10.1186/s43014-020-00022-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Abstract
Background
Conventional drying using heated air oven is commonly used as a method for preserving the product but often affects the nutritional value, taste, and texture. However, the heat from the drying method can oxidize and destroy heat-sensitive compounds. Superheated steam (SHS) drying uses superheated steam instead of hot air or combustion gases in a direct dryer and was reported better at preserving the nutritional values of food products.
Aim
To evaluate the effect of SHS drying on antioxidant properties of tea leaves. The study also compared SHS drying with conventional and freeze-drying methods.
Results
Tea leaves dried using freeze drying retained the highest level of antioxidant properties compared to other drying methods. The leaves dried using SHS exhibited significantly higher radical scavenging activity, ORAC and FRAP values compared to oven drying method. At different drying temperatures (150 °C and 175 °C), oven dried leaves showed significantly higher (p < 0.05) antioxidant properties than that of SHS dried ones. Tea leaves dried for 60, 75, and 90 min using SHS showed significantly higher (p < 0.05) FRAP and ORAC values, and also total phenolic content compared to oven dried tea leaves.
Conclusion
Tea leaves dried using SHS drying method retained higher level of antioxidant properties compared to oven drying. The drying method also retained lower antioxidant properties as drying time increased. Further study involving SHS drying in food-related fields should be conducted to support its usefulness.
Graphical abstract
Collapse
|
8
|
Numasaki H, Teshima T, Ando Y, Akuta K, Ikeda H, Okajima K, Kumano T, Sasaki T, Sekiguchi K, Tago M, Terahara A, Nakamura K, Nishimura T, Ogawa K. Japanese structure survey of radiation oncology in 2012. J Radiat Res 2020; 61:146-160. [PMID: 31825076 PMCID: PMC6976736 DOI: 10.1093/jrr/rrz077] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/27/2019] [Revised: 09/30/2019] [Indexed: 06/02/2023]
Abstract
This paper describes the ongoing structure of radiation oncology in Japan in terms of equipment, personnel, patient load and geographic distribution to identify and overcome any existing limitations. From March 2013 to August 2016, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2012. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 213 000 and 251 000, respectively. Additionally, the estimated cancer incidence was 865 238 cases with ~24.6% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 864), telecobalt (n = 0), Gamma Knife (n = 44), 60Co remote afterloading system (RALS; n = 23) and 192Ir RALS (n = 130). The LINAC system used dual-energy functions in 651 units, 3D conformal radiotherapy functions in 759 and intensity-modulated radiotherapy (IMRT) functions in 466. There were 792 Japan Radiological Society/Japanese Society for Radiation Oncology-certified radiation oncologists, 1061.6 full-time equivalent (FTE) radiation oncologists, 2124.2 FTE radiotherapy technologists, 181.3 FTE medical physicists, 170.9 FTE radiotherapy quality managers and 841.5 FTE nurses. The frequency of IMRT use significantly increased during this time. In conclusion, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility although there was a shortage of personnel in 2012.
Collapse
Affiliation(s)
- Hodaka Numasaki
- Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan
| | - Teruki Teshima
- Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, 541-8567, Japan
| | - Yutaka Ando
- Department of Radiation Oncology, Saitama Medical Center, 4-9-3 Kitaurawa, Urawa-ku, Saitama-shi, Saitama, 330-0074, Japan
| | - Keizo Akuta
- Department of Radiology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu-shi, Siga, 520-0000, Japan
| | - Hiroshi Ikeda
- Department of Radiation Oncology, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai-shi, Osaka, 593-8304, Japan
| | - Kaoru Okajima
- Department of Radiology, Kindai University Nara Hospital, 1248-1 Otoda-cho, Ikoma-shi, Nara, 630-0293, Japan
| | - Tomoyasu Kumano
- Department of Radiology, Gifu University School of Medicine, 1-1 Yanagido, Gifu-shi, Gifu, 501-1194, Japan
| | - Tomonari Sasaki
- Division of Medical Quantum Science, Department of Health Sciences, Kyushu University Faculty of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan
| | - Kenji Sekiguchi
- Sonoda-kai Radiation Oncology Clinic, 3-4-19 Hokima, Adachi-ku, Tokyo, 121-0064, Japan
| | - Masao Tago
- Department of Radiology, Teikyo University Mizonokuchi Hospital, 5-1-1 Futako, Takatsu, Kawasaki-shi, Kanagawa, 213-8507, Japan
| | - Atsuro Terahara
- Department of Radiology, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan
| | - Katsumasa Nakamura
- Department of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431-3192, Japan
| | - Tetsuo Nishimura
- Division of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan
| | - Kazuhiko Ogawa
- Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan
| | | |
Collapse
|
9
|
Numasaki H, Teshima T, Nishimura T, Akuta K, Ando Y, Ikeda H, Kamikonya N, Koizumi M, Sasaki T, Sekiguchi K, Tago M, Terahara A, Nakamura K, Nishio M, Murakami M, Mori Y, Ogawa K. Japanese Structure Survey of Radiation Oncology in 2011. J Radiat Res 2019; 60:786-802. [PMID: 31665374 PMCID: PMC7357227 DOI: 10.1093/jrr/rrz058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Revised: 04/28/2019] [Accepted: 07/19/2019] [Indexed: 06/02/2023]
Abstract
We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load and geographic distribution to identify and overcome any existing limitations. From March 2012 to August 2015, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2011. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 211 000 and 250 000, respectively. Additionally, the estimated cancer incidence was 851 537 cases with approximately 24.8% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 836), telecobalt (n = 3), Gamma Knife (n = 46), 60Co remote afterloading system (RALS; n = 24), and 192Ir RALS (n = 125). The LINAC system used dual-energy functions in 619 units, 3D conformal radiotherapy functions in 719 and intensity-modulated radiotherapy (IMRT) functions in 412. There were 756 JRS or JASTRO-certified radiation oncologists, 1018.5 full-time equivalent (FTE) radiation oncologists, 2026.7 FTE radiotherapy technologists, 149.1 FTE medical physicists, 141.5 FTE radiotherapy quality managers and 716.3 FTE nurses. The frequency of IMRT use significantly increased during this time. To conclude, although there was a shortage of personnel in 2011, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility.
Collapse
Affiliation(s)
- Hodaka Numasaki
- Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan
| | - Teruki Teshima
- Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, 541-8567, Japan
| | - Tetsuo Nishimura
- Division of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan
| | - Keizo Akuta
- Department of Radiology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu-shi, Siga, 520-0000, Japan
| | - Yutaka Ando
- Department of Radiation Oncology, Saitama Medical Center, 4-9-3 Kitaurawa, Urawa-ku, Saitama-shi, Saitama, 330-0074, Japan
| | - Hiroshi Ikeda
- Department of Radiation Oncology, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai-shi, Osaka, 593-8304, Japan
| | - Norihiko Kamikonya
- Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-shi, Hyogo, 663-8501, Japan
| | - Masahiko Koizumi
- Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan
| | - Tomonari Sasaki
- Division of Medical Quantum Science, Department of Health Sciences, Kyushu University Faculty of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan
| | - Kenji Sekiguchi
- Sonoda-kai Radiation Oncology Clinic, 3-4-19 Hokima, Adachi-ku, Tokyo, 121-0064, Japan
| | - Masao Tago
- Department of Radiology, Teikyo University Mizonokuchi Hospital, 5-1-1 Futako, Takatsu, Kawasaki-shi, Kanagawa, 213-8507, Japan
| | - Atsuro Terahara
- Department of Radiology, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan
| | - Katsumasa Nakamura
- Department of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431-3192, Japan
| | - Masamichi Nishio
- Hokkaido Cancer Center, 2-3-54 Kikusui 4jyo, Shiraishi-ku, Sapporo-shi, Hokkaido, 003-0804, Japan
| | - Masao Murakami
- Southern TOHOKU Proton Therapy Center, 172-7 Yatsuyamada, Koriyama-shi, Fukushima, 963-8563, Japan
| | - Yoshimasa Mori
- Department of Radiology and Radiation Oncology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute-shi, Aichi, 480-1195, Japan
| | - Kazuhiko Ogawa
- Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan
| | | |
Collapse
|
10
|
Ogasawara M, Matsuhisa T, Kondo T, Oshima R, Sugiura F, Niwa T, Ando Y, Sato M, Sato J, Kohri S. Pyogenic spondylitis with acute course caused by Corynebacterium simulans. J Infect Chemother 2019; 26:294-297. [PMID: 31735633 DOI: 10.1016/j.jiac.2019.10.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 10/09/2019] [Accepted: 10/15/2019] [Indexed: 11/15/2022]
Abstract
Corynebacterium simulans was first reported in 2000. Although it is a member of the normal skin flora, some cases of C. simulans infection have been reported. Other Corynebacterium spp. rarely cause chronic pyogenic spondylitis, and pyogenic spondylitis caused by C. simulans has not been reported at all. Here we report a case of acute pyogenic spondylitis due to C. simulans. A 78-year-old man with diabetes mellitus visited our hospital with a 3-day history of lower back pain and fever. Blood culture revealed C. simulans and magnetic resonance images of lumbar vertebrae showed pyogenic spondylitis. He recovered after treatment by vancomycin for 9 weeks and was discharged home. No recurrence has been observed for half a year. This is likely the first reported case of pyogenic spondylitis by C. simulans. In general, Corynebacterium spp. cause chronic pyogenic spondylitis, but this case showed an acute course.
Collapse
Affiliation(s)
- M Ogasawara
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
| | - T Matsuhisa
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - T Kondo
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan; Center for Postgraduate Clinical Training and Career Development, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - R Oshima
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - F Sugiura
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - T Niwa
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - Y Ando
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - M Sato
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - J Sato
- Department of General Medicine, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| | - S Kohri
- Center for Medical Education, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya, Aichi, 466-8560, Japan
| |
Collapse
|
11
|
Matsuoka A, Tsubata Y, Mizutani T, Takahashi M, Shimodaira H, Hamamoto Y, Nagashima F, Ando Y. DEVELOPMENT AND DISTRIBUTION OF THE JAPANESE EDITION OF SIOG EDUCATIONAL MATERIALS. J Geriatr Oncol 2019. [DOI: 10.1016/s1879-4068(19)31310-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
Matsuoka A, Mitsuma A, Maeda O, Tsunoda N, Kikumori T, Ando Y. A longitudinal tracking and quantitative assessment of paclitaxel-induced peripheral neurotoxicity. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz265.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Ma Y, Ueda M, Ueda A, Yamashita T, Ando Y. A rapid screening method for CADASIL by means of dot blot analyses using biopsied skin samples. J Neurol Sci 2019. [DOI: 10.1016/j.jns.2019.10.1529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Ando Y, Tanioka T, Nakazawa K, Yasuda N. Evaluation of autonomic activation after maximal cycling exercise in adolescent boys and girls. J Sci Med Sport 2019. [DOI: 10.1016/j.jsams.2019.08.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
15
|
Wick W, Tabatabai G, Schuler M, Rorhberg K, Chawla S, Janku F, Schiff D, Heinemann V, Narita Y, Ando Y, Lenz H, Ikeda M, Genvresse I, Rentzsch C, Reschke S, Cyris C, Cai C, Jeffers M, Peña C, Bähr O. Safety, efficacy, PK and PD biomarker results of the first-in-human study of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor BAY 1436032 in patients (pts) with mIDH1 advanced solid tumours. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz244.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
16
|
Sakai K, Ueda M, Fukushima W, Tamaoka A, Shoji M, Ando Y, Yamada M. Nationwide survey on cerebral amyloid angiopathy in Japan. Eur J Neurol 2019; 26:1487-1493. [PMID: 31232495 DOI: 10.1111/ene.14031] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Accepted: 06/18/2019] [Indexed: 11/28/2022]
Abstract
BACKGROUND AND PURPOSE A nationwide survey was conducted to understand the epidemiology of cerebral amyloid angiopathy-related intracerebral hemorrhage (CAA-related ICH) and cerebral amyloid angiopathy-related inflammation/vasculitis (CAA-ri) in Japan. METHODS To estimate the total number and clinical features of patients with CAA-related ICH and CAA-ri between January 2012 and December 2014 and to analyze their clinical features, questionnaires were sent to randomly selected hospitals in Japan. RESULTS In the first survey, 2348 of 4657 departments responded to the questionnaire (response rate 50.4%). The total numbers of reported patients with CAA-related ICH and CAA-ri were 1338 and 61, respectively, and their total numbers in Japan were estimated to be 5900 [95% confidence interval (CI) 4800-7100] and 170 (95% CI 110-220), respectively. The crude prevalence rates were 4.64 and 0.13 per 100 000 population, respectively. The clinical information of 474 patients with CAA-related ICH obtained in the second survey was as follows: (i) the average age of onset was 78.4 years; (ii) the prevalence increased with age; (iii) the disease was common in women; and (iv) hematoma most frequently occurred in the frontal lobe. Sixteen patients with CAA-ri for whom data were collected in the second survey had the following characteristics: (i) median age of onset was 75 years; (ii) cognitive impairment and headache were the most frequent initial manifestations; and (iii) focal neurological signs, such as motor paresis and visual disturbance, were frequently observed during the clinical course. CONCLUSIONS The numbers of patients with CAA-related ICH and CAA-ri in Japan were estimated.
Collapse
Affiliation(s)
- K Sakai
- Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
| | - M Ueda
- Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
| | - W Fukushima
- Department of Public Health, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - A Tamaoka
- Department of Neurology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | - M Shoji
- Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Y Ando
- Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
| | - M Yamada
- Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
| |
Collapse
|
17
|
Iio K, Kabata D, Iio R, Imai Y, Hatanaka M, Omori H, Hoshida Y, Saeki Y, Shintani A, Hamano T, Isaka Y, Ando Y. Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease. Sci Rep 2019; 9:813. [PMID: 30692566 PMCID: PMC6349929 DOI: 10.1038/s41598-018-37511-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Accepted: 12/07/2018] [Indexed: 02/06/2023] Open
Abstract
Premature immune ageing, including thymic atrophy, is observed in patients with chronic kidney disease (CKD). Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), which are mineral and bone disorder (MBD)-related factors, affect immune cells and possibly cause thymic atrophy. We examined the cross-sectional association between thymic atrophy, evaluated as the number of CD3+CD4+CD45RA+CD31+ cells [recent thymic emigrants (RTE)/μL], and MBD-related factors [(serum PTH, FGF23, and alkaline phosphatase (ALP) level] in 125 patients with non-dialysis dependent CKD. Median estimated glomerular filtration rate (eGFR) was 17 mL/min/1.73 m2. Older age (r = −0.46), male sex (r = −0.34), lower eGFR (r = 0.27), lower serum-corrected calcium (r = 0.27), higher PTH (r = −0.36), and higher ALP level (r = −0.20) were identified as determinants of lower number of RTE. In contrast, serum concentrations of FGF23 and phosphorus were not correlated with RTE. Multivariate non-linear regression analysis indicated a negative association between serum PTH and log-transformed RTE (P = 0.030, P for non-linearity = 0.124). However, the serum levels of FGF23 and ALP were not associated with RTE. In patients with CKD, serum PTH concentrations were related to thymic atrophy which contributes to immune abnormality.
Collapse
Affiliation(s)
- Kenichiro Iio
- Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.
| | - Daijiro Kabata
- Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Rei Iio
- Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan
| | - Yosuke Imai
- Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
| | - Masaki Hatanaka
- Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
| | - Hiroki Omori
- Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
| | - Yoshihiko Hoshida
- Department of Pathology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
| | - Yukihiko Saeki
- Department of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
| | - Ayumi Shintani
- Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Takayuki Hamano
- Department of Inter-Organ Communication Research in Kidney Disease, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yoshitaka Isaka
- Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yutaka Ando
- Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan
| |
Collapse
|
18
|
Numasaki H, Teshima T, Nishimura T, Akuta K, Ando Y, Ikeda H, Kamikonya N, Koizumi M, Sasaki T, Sekiguchi K, Tago M, Terahara A, Nakamura K, Nishio M, Murakami M, Mori Y, Ogawa K. Japanese structure survey of radiation oncology in 2010. J Radiat Res 2019; 60:80-97. [PMID: 30137391 PMCID: PMC6373681 DOI: 10.1093/jrr/rry044] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Indexed: 06/02/2023]
Abstract
We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load, and geographic distribution to identify and overcome any existing limitations. From March 2011 to June 2013, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2010. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 211 000 and 251 000, respectively. Additionally, the estimated cancer incidence was 805 236 cases, with ~26.2% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 829), telecobalt (n = 9), Gamma Knife (n = 46), 60Co remote afterloading system (RALS; n = 28), and 192Ir RALS (n = 131). The LINAC system used dual-energy functions in 586 units, three-dimensional conformal radiotherapy functions in 663, and intensity-modulated radiotherapy (IMRT) functions in 337. There were 564 JASTRO-certified radiation oncologists, 959.2 full-time equivalent (FTE) radiation oncologists, 1841.3 FTE radiotherapy technologists, 131.3 FTE medical physicists, 121.5 FTE radiotherapy quality managers, and 649.6 FTE nurses. The frequency of IMRT use significantly increased during this year. To conclude, although there was a shortage of personnel in 2010, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility.
Collapse
Affiliation(s)
- Hodaka Numasaki
- Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, Japan
| | - Teruki Teshima
- Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, Japan
| | - Tetsuo Nishimura
- Division of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
| | - Keizo Akuta
- Department of Radiology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu-shi, Siga, Japan
| | - Yutaka Ando
- Department of Radiation Oncology, Saitama Medical Center, 4-9-3 Kitaurawa, Urawa-ku, Saitama-shi, Saitama, Japan
| | - Hiroshi Ikeda
- Department of Radiation Oncology, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai-shi, Osaka, Japan
| | - Norihiko Kamikonya
- Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-shi, Hyogo, Japan
| | - Masahiko Koizumi
- Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, Japan
| | - Tomonari Sasaki
- Division of Medical Quantum Science, Department of Health Sciences, Kyushu University Faculty of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan
| | - Kenji Sekiguchi
- Sonoda-kai Radiation Oncology Clinic, 3-4-19 Hokima, Adachi-ku, Tokyo, Japan
| | - Masao Tago
- Department of Radiology, Teikyo University Mizonokuchi Hospital, 5-1-1 Futako, Takatsu, Kawasaki-shi, Kanagawa, Japan
| | - Atsuro Terahara
- Department of Radiology, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo, Japan
| | - Katsumasa Nakamura
- Department of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, Japan
| | - Masamichi Nishio
- Hokkaido Cancer Center, 2-3-54 Kikusui 4jyo, Shiraishi-ku, Sapporo-shi, Hokkaido, Japan
| | - Masao Murakami
- Southern TOHOKU Proton Therapy Center, 172-7 Yatsuyamada, Koriyama-shi, Fukushima, Japan
| | - Yoshimasa Mori
- Department of Radiology and Radiation Oncology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute-shi, Aichi, Japan
| | - Kazuhiko Ogawa
- Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, Japan
| | | |
Collapse
|
19
|
Matsuoka A, Maeda O, Mitsuma A, Uehara K, Nakayama G, Nagino M, Kodera Y, Ando Y. A longitudinal study of a new point-of-care nerve conduction device for quantitative assessment of chemotherapy-induced peripheral neurotoxicity. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy300.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Abstract
SummaryThe effects of verapamil, a coronary vasodilator, on platelet functions were studied.Platelet aggregation induced by ADP, epinephrine or collagen was inhibited by verapamil in vitro. Calcium ionophore A23187-induced platelet aggregation was also inhibited by verapamil in a concentration dependent manner. In washed platelets, verapamil caused a dose-dependent inhibition of serotonin release induced either by thrombin or A23187 in the absence of extracellular calcium. Addition of 1 mM CaCl2 with A23187 or thrombin partially overcame this inhibition. Addition of 1 mM CaCl2 in the absence of verapamil had no effect on thrombin- or A23187-induced secretion. When verapamil was administered to the healthy volunteers at the dosage commonly used, inhibition of platelet aggregation was observed 2 hrs after the drug ingestion. It is of great interest that verapamil potentiated the anti-aggregating activity of prostacyclin in vitro.Our results may suggest a potential role for verapamil in the treatment of thrombotic disorders.
Collapse
Affiliation(s)
- Y Ikeda
- The Department of Hematology, Keio University, School of Medicine, Tokyo, Japan
| | - M Kikuchi
- The Department of Hematology, Keio University, School of Medicine, Tokyo, Japan
| | - K Toyama
- The Department of Hematology, Keio University, School of Medicine, Tokyo, Japan
| | - K Watanabe
- Department of Clinical Pathology, Keio University, School of Medicine, Tokyo, Japan
| | - Y Ando
- Department of Clinical Pathology, Keio University, School of Medicine, Tokyo, Japan
| |
Collapse
|
21
|
Sato M, Uematsu M, Hama Y, Kondo M, Kutsuki S, Shigematsu N, Ando Y, Kusano S, Kubo A. Low-Dose Induction Radiotherapy for Stomach Conservation in Patients with Massive Gastric Lymphoma. Tumori 2018; 86:286-8. [PMID: 11016705 DOI: 10.1177/030089160008600405] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Low-dose induction radiotherapy was performed in 4 patients with massive gastric lymphoma in order to treat the disease without gastrectomy. Following the radiotherapy, gastric lesions had shrunk considerably without any complications. Standard chemotherapy and/or radiotherapy could then be performed safely, and stomach conservation could be achieved in all 4 patients.
Collapse
Affiliation(s)
- M Sato
- Radiation Oncology, Keio University School of Medicine, Shinjuku, Tokyo, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Gyawali B, Shimokata T, Ando M, Honda K, Ando Y. Risk of serious adverse events and fatal adverse events with sorafenib in patients with solid cancer: a meta-analysis of phase 3 randomized controlled trials†. Ann Oncol 2017; 28:246-253. [PMID: 27771613 DOI: 10.1093/annonc/mdw549] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Background Sorafenib is a multikinase-tyrosine kinase inhibitor commonly used in a variety of cancers. There are concerns about the increased risk of serious adverse events (SAEs) and fatal adverse events (FAEs) with sorafenib. We performed an up-to-date meta-analysis of all phase 3 randomized controlled trials (RCTs) of sorafenib to quantify the increased risk of SAEs and FAEs. Patients and methods We carried out a systematic search of electronic databases for studies published from inception to February 2016 without any restrictions. Eligibility criteria included phase 3 RCTs of solid tumors comparing sorafenib, alone or in combination with nontargeted chemotherapy (Sorafenib arm) versus placebo or nontargeted chemotherapy (control arm). Data on SAEs and FAEs for both the arms were extracted from each study and pooled to determine the overall incidence, relative risks (RRs) and 95% Confidence Intervals (CIs). Results Of 471 studies identified, a total of 12 phase 3 RCTs involving 6797 solid cancer patients comparing sorafenib with control met the eligibility criteria and were included. The overall incidence of SAEs and FAEs with sorafenib were 26.4% (95% CI, 18.0-36.9%) and 1.3% (95% CI: 0.8-2.2%), respectively. Compared with control, sorafenib use significantly increased the risk of both SAEs (RR: 1.49, 95% CI: 1.18-1.89, P = 0.001) and FAEs (RR: 1.82, 95% CI: 1.05-3.14, P = 0.033). This association varied significantly with cancer types (P < 0.001) and approval status (P = 0.012) for SAEs but no evidence of heterogeneity was found for FAEs. Conclusions This meta-analysis of phase 3 RCTs demonstrates an increased risk of both SAEs and FAEs with sorafenib use in adult patients with solid cancers. This quantification of increased risks of SAEs and FAEs will be important in considering the trade-off of sorafenib treatment during shared decision-making.
Collapse
Affiliation(s)
- B Gyawali
- Department of Clinical Oncology and Chemotherapy, Nagoya University Graduate School of Medicine, Nagoya
| | - T Shimokata
- Department of Clinical Oncology and Chemotherapy, Nagoya University Graduate School of Medicine, Nagoya
| | - M Ando
- Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
| | - K Honda
- Department of Clinical Oncology and Chemotherapy, Nagoya University Graduate School of Medicine, Nagoya
| | - Y Ando
- Department of Clinical Oncology and Chemotherapy, Nagoya University Graduate School of Medicine, Nagoya
| |
Collapse
|
23
|
Maeda O, Yokoyama Y, Yamaguchi J, Ota A, Matsuoka A, Morita S, Inoue M, Mizutani T, Shimokata T, Urakawa H, Mitsuma A, Nagino M, Ando Y. Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.040] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Kato Y, Yamashita T, Ueda M, Masuda T, Misumi Y, Nomura T, Kosaka T, Ando Y. Tafamidis or liver transplantation: Which should be chosen for hereditary transthyretin amyloidosis? J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
25
|
Mukaino A, Nakane S, Higuchi O, Kosaka T, Maeda Y, Takamatsu K, Masuda T, Matsuo H, Ando Y. Clinical features of ganglionic acetylcholine receptor β4 subunit seropositive autoimmune autonomic ganglionopathy and utility of 123I-MIBG myocardial scintigraphy. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
Ueda M, Misumi Y, Masuda T, Tsuda Y, Inoue Y, Tasaki M, Yamashita T, Ando Y. Amyloid formation and toxicity of fragmented transthyretin. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Ikenoshita S, Ikeda T, Nakahara K, Masuda T, Yamashita S, Ando Y. Evaluation of MIBG scintigraphy in the movement disorder society Parkinson’s Disease criteria. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Doki T, Yamashita S, Wei F, Zhang X, Zhang Z, Tawara N, Hino H, Uyama E, Araki K, Ando Y. Polyalanine expansion in PABPN1 causes mitochondrial dysfunction. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Nakajima M, Watari M, Uyama E, Honda S, Suga T, Ando Y. Deep venous thrombosis in patients with neuromuscular disorders: A multicenter, prospective study. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
30
|
Nakane S, Mukaino A, Higuchi O, Maeda Y, Takamatsu K, Watari M, Kosaka T, Matsuo H, Ando Y. Ganglionic acetylcholine receptor antibodies in autoimmune autonomic ganglionopathy: Characteristics, clinical features and outcomes. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Yamashita T, Mitsuharu U, Misumi Y, Masuda T, Nomura T, Tasaki M, Matsumoto S, Takamatsu K, Obayashi K, Ando Y. Genetical and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas in japan. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Tawara N, Yamashita S, Zhang X, Zhang Z, Doki T, Matsuo Y, Nakane S, Maeda Y, Ando Y. Predominant atrophy in type 2 myofibers of sporadic inclusion body myositis with anti-cn1a autoantibody. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda S, Katsuno M, Sobue G. Vasculopathy in familial amyloid polyneuropathy. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
34
|
Singu T, Mizutani H, Matsubara S, Naganuma M, Ikeno K, Inatomi Y, Yonehara T, Ando Y. Selection of direct oral anticoagulants for secondary prevention may shorten the length of hospital stay in patients with cardioembolic stroke due to non-valvular atrial fibrillation. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
35
|
Nomura T, Misumi Y, Ueda M, Masuda T, Yamashita T, Ando Y. Microvascular pathology of hereditary transthyretin amyloidosis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
36
|
Murakami Y, Nakajima M, Ueda A, Uetani H, Kitajima M, Ando Y. The utility of enhanced 3D-turbo spin echo sequence in assessment of intracranial vasculitis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
37
|
Zhang Z, Yamashita S, Tawara N, Kawakami K, Doki T, Matsuo Y, Zhang X, Maeda Y, Ando Y. Mitochondrial analysis in wild-type TDP-43 transgenic mice mimicking sporadic inclusion body myositis. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Nagatoshi C, Masuda T, Ueda M, Misumi Y, Nomura T, Tasaki M, Yamashita T, Obayashi K, Ando Y. Pupillary autonomic nervous dysfunction in hereditary transthyretin amyloidosis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Takamatsu K, Nakane S, Kosaka T, Saruwatari K, Saeki S, Kimura T, MIyashita A, Fukushima S, Ihn H, Ando Y. Neuromuscular adverse events triggered by immune checkpoint inhibitors. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Watari M, Nakane S, Mukaino A, Nakajima M, Masuda T, Takamatsu K, Mori Y, Kouzaki Y, Higuchi O, Matsuo H, Ando Y. Autoimmune basis in postural Orthostatic Tachycardia syndrome. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Satoshi Y, Matsuo Y, Tawara N, Zhang X, Zhang Z, Doki T, Ando Y. CYLD is involved in the pathogenesis of inclusion body myositis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Inatomi Y, Nakajima M, Yonehara T, Ando Y. Ipsilateral hemiparesis in ischemic stroke patients. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
43
|
Yamakawa M, Hashimoto Y, Sakamoto T, Yamamoto F, Ito Y, Tajiri S, Watari M, Nakajima M, Ando Y. Clinical features of patients presenting reversible cerebral vasoconstriction without thunderclap headache. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
44
|
Akimitsu H, Ueda M, Tasaki M, Matsumoto S, Mizukami M, Misumi Y, Masuda T, Yamashita T, Obayashi K, Ando Y. A novel amyloid protein causing systemic venous amyloidosis in the elderly. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
45
|
Murahashi S, Amano T, Kouzaki Y, Ando Y. Trial of “Sanmitsu Yuga” of traditional Mikkyo Buddhism as neurological rehabilitation. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Misumi Y, Kinoshita Y, Nomura T, Ueda M, Masuda T, Yamashita T, Ando Y. Effects of fibroblasts on the morphology of transthyretin amyloid deposition. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Subbarao GV, Arango J, Masahiro K, Hooper AM, Yoshihashi T, Ando Y, Nakahara K, Deshpande S, Ortiz-Monasterio I, Ishitani M, Peters M, Chirinda N, Wollenberg L, Lata JC, Gerard B, Tobita S, Rao IM, Braun HJ, Kommerell V, Tohme J, Iwanaga M. Genetic mitigation strategies to tackle agricultural GHG emissions: The case for biological nitrification inhibition technology. Plant Sci 2017; 262:165-168. [PMID: 28716411 DOI: 10.1016/j.plantsci.2017.05.004] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/06/2017] [Accepted: 05/01/2017] [Indexed: 05/16/2023]
Abstract
Accelerated soil-nitrifier activity and rapid nitrification are the cause of declining nitrogen-use efficiency (NUE) and enhanced nitrous oxide (N2O) emissions from farming. Biological nitrification inhibition (BNI) is the ability of certain plant roots to suppress soil-nitrifier activity, through production and release of nitrification inhibitors. The power of phytochemicals with BNI-function needs to be harnessed to control soil-nitrifier activity and improve nitrogen-cycling in agricultural systems. Transformative biological technologies designed for genetic mitigation are needed, so that BNI-enabled crop-livestock and cropping systems can rein in soil-nitrifier activity, to help reduce greenhouse gas (GHG) emissions and globally make farming nitrogen efficient and less harmful to environment. This will reinforce the adaptation or mitigation impact of other climate-smart agriculture technologies.
Collapse
Affiliation(s)
- G V Subbarao
- Japan International Research Center for Agricultural Sciences (JIRCAS), 1-1 Ohwashi, Tsukuba, Ibaraki 305-8686, Japan.
| | - J Arango
- International Center for Tropical Agriculture (CIAT), A.A. 6713, Cali, Colombia
| | - K Masahiro
- International Maize and Wheat Improvement Center (CIMMYT), Mexico-Veracruz, Elbatan, Texcoco CP 56237, Edo.de Mexico, Mexico
| | - A M Hooper
- Rothamsted Research, Harpenden, AL5 2JO, UK
| | - T Yoshihashi
- Japan International Research Center for Agricultural Sciences (JIRCAS), 1-1 Ohwashi, Tsukuba, Ibaraki 305-8686, Japan
| | - Y Ando
- Japan International Research Center for Agricultural Sciences (JIRCAS), 1-1 Ohwashi, Tsukuba, Ibaraki 305-8686, Japan
| | - K Nakahara
- Japan International Research Center for Agricultural Sciences (JIRCAS), 1-1 Ohwashi, Tsukuba, Ibaraki 305-8686, Japan
| | - S Deshpande
- International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), Hyderabad, Telangana, India
| | - I Ortiz-Monasterio
- International Maize and Wheat Improvement Center (CIMMYT), Mexico-Veracruz, Elbatan, Texcoco CP 56237, Edo.de Mexico, Mexico
| | - M Ishitani
- International Center for Tropical Agriculture (CIAT), A.A. 6713, Cali, Colombia
| | - M Peters
- International Center for Tropical Agriculture (CIAT), A.A. 6713, Cali, Colombia
| | - N Chirinda
- International Center for Tropical Agriculture (CIAT), A.A. 6713, Cali, Colombia
| | - L Wollenberg
- CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), University of Vermont, Burlington, VT 05405, USA
| | - J C Lata
- Sorbonne Universites, UPMC Univ. Paris 06, IRD, CNRS, INRA, UPEC, Univ. Paris Diderot, Institute of Ecology and Environmental Sciences, iEES Paris, 4 place Jussieu, 75005 Paris, France
| | - B Gerard
- International Maize and Wheat Improvement Center (CIMMYT), Mexico-Veracruz, Elbatan, Texcoco CP 56237, Edo.de Mexico, Mexico
| | - S Tobita
- Japan International Research Center for Agricultural Sciences (JIRCAS), 1-1 Ohwashi, Tsukuba, Ibaraki 305-8686, Japan
| | - I M Rao
- International Center for Tropical Agriculture (CIAT), A.A. 6713, Cali, Colombia
| | - H J Braun
- International Maize and Wheat Improvement Center (CIMMYT), Mexico-Veracruz, Elbatan, Texcoco CP 56237, Edo.de Mexico, Mexico
| | - V Kommerell
- International Maize and Wheat Improvement Center (CIMMYT), Mexico-Veracruz, Elbatan, Texcoco CP 56237, Edo.de Mexico, Mexico
| | - J Tohme
- International Center for Tropical Agriculture (CIAT), A.A. 6713, Cali, Colombia
| | - M Iwanaga
- Japan International Research Center for Agricultural Sciences (JIRCAS), 1-1 Ohwashi, Tsukuba, Ibaraki 305-8686, Japan
| |
Collapse
|
48
|
Tomomatsu J, Iwasa S, Saka H, Takahashi S, Nakano K, Morita S, Inoue M, Nakahama H, Kogure Y, Kakizume T, Natsume K, Aoki T, Quadt C, Yamada Y, Ando Y. A phase 1 study of BYL719, an α-isoform selective PI3K inhibitor, in Japanese patients with advanced solid malignancies. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
49
|
Gyawali B, Shimokata T, Ando Y. Correlation and differences in Effect sizes between Progression Free Survival (PFS) and Overall Survival (OS) among PD-1 inhibitors. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx376.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Nishimura M, Kato Y, Tanaka T, Taki H, Tone A, Yamada K, Suzuki S, Saito M, Ando Y, Hoshiyama Y. Effect of Home Blood Pressure on Inducing Remission/Regression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus. Am J Hypertens 2017; 30:830-839. [PMID: 28605498 DOI: 10.1093/ajh/hpx050] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Accepted: 03/16/2017] [Indexed: 01/21/2023] Open
Abstract
BACKGROUND The Home Blood Pressure for Diabetic Nephropathy study is a prospective observational study conducted to determine the effect of home blood pressure (HBP) on remission/regression of microalbuminuria in patients with type 2 diabetes mellitus (DM). METHODS Patients with type 2 DM having microalbuminuria were followed-up for 3 years. Remission of microalbuminuria was defined as shift from microalbuminuria to normoalbuminuria. Regression of microalbuminuria was defined as a 50% reduction in urinary albumin-creatinine ratio from baseline. All measurements of morning and evening HBP were averaged every year and defined as all HBP. RESULTS In total, 235 patients were followed up. The 3-year cumulative incidences of remission and regression were 32.3% and 44.7%, respectively. Following analysis of all cases, the degree of decline in all home systolic blood pressure (AHSBP), rather than mean AHSBP, influenced the incidence of remission/regression. There was a strong relationship between the decline in AHSBP during the follow-up period and AHSBP at baseline. Therefore, separate analyses of the patients with AHSBP below 140 mm Hg at baseline were performed, which revealed that mean AHSBP during the follow-up period independently affected the incidence of remission/regression. The hazard ratio for inducing remission/regression was significantly lower in patients with AHSBP during the follow-up period above 130 mm Hg than in those with AHSBP below 120 mm Hg. CONCLUSIONS Optimal AHSBP for the induction of remission/regression of microalbuminuria might be below 130 mm Hg. It is required to confirm whether keeping AHSBP below 130 mm Hg leads to subsequent renoprotection or not. CLINICAL TRIALS REGISTRATION Trial Number UMIN000000804.
Collapse
Affiliation(s)
- Motonobu Nishimura
- Department of Diabetes and Endocrinology, National Hospital Organization Chiba-East National Hospital, Chiba, Japan
| | - Yasuhisa Kato
- Department of Diabetes and Endocrinology, National Hospital Organization Nagoya Medical Center, Aichi, Japan
| | - Tsuyoshi Tanaka
- Department of Endocrinology and Metabolism, National Hospital Organization Mie Chuo Medical Center, Mie, Japan
| | - Hideki Taki
- Department of Diabetes, National Hospital Organization Osaka Medical Center, Osaka, Japan
| | - Atsuhito Tone
- Department of Diabetes and Metabolism, National Hospital Organization Okayama Medical Center, Okayama, Japan
| | - Kazunori Yamada
- Department of Diabetes, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
| | - Seiji Suzuki
- Department of Diabetes and Endocrinology, National Hospital Organization Saigai Medical Center, Tokyo, Japan
| | - Miho Saito
- Department of Internal Medicine, National Hospital Organization Tokushima National Hospital, Tokushima, Japan
| | - Yutaka Ando
- Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Osaka, Japan
| | | |
Collapse
|